Skip to main navigation Skip to search Skip to main content

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

Morten L Hansen, Rikke Sørensen, Mette T Clausen, Marie Louise Fog-Petersen, Jakob Raunsø, Niels Gadsbøll, Gunnar H Gislason, Fredrik Folke, Søren Andersen, Tina K Schramm, Steen Z Abildstrøm, Henrik E Poulsen, Lars Køber, Christian Torp-Pedersen

816 Citations (Scopus)

Abstract

Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.
Original languageEnglish
JournalArchives of Internal Medicine
Volume170
Issue number16
Pages (from-to)1433-41
Number of pages9
DOIs
Publication statusPublished - 13 Sept 2010

Fingerprint

Dive into the research topics of 'Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation'. Together they form a unique fingerprint.

Cite this